Table 1.

Characteristics of the 25 Recruited Participants (Including Those Who Dropped Out Before the End of the Intervention) at Baseline.

	Experimental Group, N = 8	Control Group, N = 11	Dropped Out Participants, N = 6
	Median (Q1, Q3) or n (%)	Median (Q1, Q3) or n (%)	Median (Q1, Q3) or n (%)
Age (years)	45.9 (44.6, 47.3)	45.5 (41.7, 47.0)	51.0 (45.4, 57.7)
Time since treatment (years)	1.0 (0.7, 1.8)	1.2 (0.6, 2.0)	1.4 (0.6, 2.2)
Cancer type
Breast cancer	7 (87%)	11 (100%)	6 (100%)
Endometrial cancer	1 (13%)	0 (0%)	0 (0%)
Cancer stage
Stage 1	2 (25%)	3 (27%)	3 (50%)
Stage 2	0 (0%)	3 (27%)	1 (17%)
Stage 3	6 (75%)	5 (46%)	2 (33%)
Treatment
Surgery (yes)	6 (75%)	10 (91%)	6 (100%)
Radiotherapy (yes)	7 (87%)	10 (91%)	2 (33%)
Chemotherapy (yes)	6 (75%)	9 (82%)	3 (50%)
Additional treatment
Hormone therapy	2 (25%)	5 (46%)	3 (50%)
Immunotherapy	0 (0%)	1 (9%)	1 (17%)
No additional treatment	6 (75%)	5 (46%)	1 (17%)